# EDGAR Filing Document

**Accession Number:** 0001866547
**File Stem:** 0001641172-25-018689
**Filing Date:** 2025-7
**Character Count:** 25102
**Document Hash:** ac3f17aa397bb451b4983c42f9721429
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001641172-25-018689.hdr.sgml**: 20250711

**ACCESSION NUMBER**: 0001641172-25-018689

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 15

**CONFORMED PERIOD OF REPORT**: 20250711

**ITEM INFORMATION**: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

**ITEM INFORMATION**: Submission of Matters to a Vote of Security Holders

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20250711

**DATE AS OF CHANGE**: 20250711

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Aetherium Acquisition Corp
- **CENTRAL INDEX KEY:** 0001866547
- **STANDARD INDUSTRIAL CLASSIFICATION:** BLANK CHECKS [6770]
- **ORGANIZATION NAME:** 05 Real Estate & Construction
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41189
- **FILM NUMBER:** 251117749

**BUSINESS ADDRESS:**
- **STREET 1:** 79B PEMBERWICK RD.
- **CITY:** GREENWICH
- **STATE:** CT
- **ZIP:** 06831
- **BUSINESS PHONE:** (650) 450-6836

**MAIL ADDRESS:**
- **STREET 1:** 79B PEMBERWICK RD.
- **CITY:** GREENWICH
- **STATE:** CT
- **ZIP:** 06831

?xml version='1.0' encoding='ASCII'?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**Form 8-K**

**Current Report**

**Pursuant to Section 13 or 15(d) of the**

**Securities Exchange Act of 1934**

Date of Report (Date of earliest event reported): **July 11, 2025 (July 7, 2025)**

**<u>Aetherium Acquisition Corp.</u>**

(Exact Name of Registrant as Specified in its Charter)

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-41189** | **86-3449713** |
| (State or other jurisdiction<br> of incorporation) | (Commission<br> File Number) | (I.R.S. Employer<br> Identification No.) |

---

---

| | |
|:---|:---|
| **79B Pemberwick Rd.**<br> **Greenwich, CT** | **06831** |
| (Address of Principal Executive Offices) | (Zip Code) |

---

Registrant's telephone number, including area code: **(650) 450-6836**

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbol | Name of each exchange on which registered |
| Units, each consisting of one share of Class A Common Stock and one Redeemable Warrant | GMFIU | N/A |
| Class A Common Stock, par value $0.0001 per share | GMFI | N/A |
| Warrants | GMFIW | N/A |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

**Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.**

The disclosure contained in Item 5.07 of this Current Report on Form 8-K is incorporated by reference in this Item 5.03.

**Item 5.07 Submission of Matters to a Vote of Security Holders.**

On July 7, 2025, the Company held a special meeting (the "**Extension Meeting**") to:

1) amend the Company's certificate of incorporation (the "**Charter Amendment Proposal**") to extend the date by which the Company has to consummate an initial business combination to fifty-one (51) months from the effectiveness date of the Company's Form S-1 by the SEC, which was December 29, 2021, by depositing into the Trust Account (defined below) $10,000 for each one-month extension;

2) amend the Company's investment management trust agreement, dated as of December 29, 2021, as subsequently amended (the "**Trust Agreement**"), by and between the Company and Continental Stock Transfer & Trust Company (the "**Trustee**"), to allow the Company to extend the Extended Termination Date to fifty-one (51) months from the effectiveness date of the Company's Form S-1 by the SEC, which was December 29, 2021, until March 29, 2026, (the "**Trust Amendments Proposal**").

The proposal to adjourn the Extension Meeting to a later date (the "**Adjournment Proposal**") was not presented because there were sufficient votes to approve each of the foregoing proposals.

As previously reported, on June 13, 2025, the Company issued a press release postponing the Meeting from 8:30 a.m. Eastern Time on June 13, 2025 to 8:30 a.m. Eastern Time on June 27, 2025, and on June 26, 2025, to allow time for additional votes on the proposals, the Company postponed the Meeting to July 7, 2025.

There were 1,702,285 Public Shares outstanding and there were 5,105,784 shares of Class A common stock (of which 2,874,999 are non-redeemable shares of Class A common stock that were converted from Founder Shares and 528,500 are shares underlying the Private Placement Units) and one share of Class B common stock for a total of 5,105,785 shares of Common Stock outstanding on the record date for the Extension Meeting, May 9, 2025. At the Extension Meeting, there were 3,384,144 shares of Common Stock present in person or by proxy, representing approximately 66.28% of the total shares of Common Stock outstanding as of the record date, which constituted a quorum.

The final voting results for the Charter Amendment Proposal were as follows:

---

| | | |
|:---|:---|:---|
| **For** | **Against** | **Abstain** |
| 3,384,139 (66.28% of outstanding) | 5 | 0 |

---

The final voting results for the Trust Amendments Proposal were as follows:

---

| | | |
|:---|:---|:---|
| **For** | **Against** | **Abstain** |
| 3,384,139 (66.28% of outstanding) | 5 | 0 |

---

Shareholders holding 1,693,044 public shares of the Company's shares of Class A Common Stock validly exercised and did not, as of the date of this Form 8-K, revoke their right to redeem such shares for a pro rata portion of the funds in the Company's Trust Account. As a result, assuming no redemption elections are reversed following the date of this 8-K and prior to the payment of funds from the Trust Account to such redeeming holders, approximately $20.333 million (expected to be approximately $12.01 per share) may be removed from the Trust Account to pay such holders. While the Company remains in active discussions with certain major stockholders with respect to reversing their redemption elections prior to making the redemption payments, but there can be no assurances that any agreement to this effect will be reached with such major stockholders prior to the payment of funds from the Trust Account to such holders and the irrevocable redemption of their Class A Common Stock.

The Charter Amendment, effective as of July 7, 2025, is attached as Exhibit 3.1 hereto and is incorporated by reference. The Company filed the Charter Amendment with the State of Delaware on July 10, 2025.

Amendment No. 3 to the Trust Agreement, effective as of July 7, 2025, is attached as Exhibit 3.2 hereto and is incorporated by reference.

**Forward Looking Statements**

This Current Report on Form 8-K includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Certain of these forward-looking statements can be identified by the use of words such as "believes," "expects," "intends," "plans," "estimates," "assumes," "may," "should," "will," "seeks," or other similar expressions. Such statements are subject to certain risks and uncertainties that may cause the Company's actual results to differ from the expectations expressed in the forward-looking statements. There can be no assurance that the Company will achieve such expectations. The forward-looking statements contained in this report speak only as of the date of this report and the Company undertakes no obligation to publicly update any forward-looking statements to reflect changes in information, events or circumstances after the date of this report, unless required by law.

**Item 9.01 Financial Statements and Exhibits.**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Exhibits

---

| | |
|:---|:---|
| Exhibit No. | Description |
| 3.1 | [Third Amendment to the Amended And Restated Certificate of Incorporation of Aetherium Acquisition Corp.](ex3-1.htm) |
| 10.1 | [Amendment No. 4 to the Trust Agreement, effective as of July 7, 2025 between Aetherium Acquisition Corp and Continental Stock Transfer and Trust Company](ex10-1.htm) |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). |

---

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
| Dated: July 11, 2025 |  |  |
|  | AETHERIUM ACQUISITION CORP. | AETHERIUM ACQUISITION CORP. |
|  | By: | */s/ Jonathan Chan* |
|  | Name: | Jonathan Chan |
|  | Title: | Chief Executive Officer and Chairman |

---

## Exhibit 3.1

**Exhibit 3.1**

**THIRD AMENDMENT TO THE**

**AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF**

**AETHERIUM ACQUISITION CORP.**

July 7, 2025

Aetherium Acquisition Corp., a corporation organized and existing under the laws of the State of Delaware (the "**<u>Corporation</u>**"), DOES HEREBY CERTIFY AS FOLLOWS:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. The name of the Corporation is "Aetherium Acquisition Corp." The original certificate of incorporation of the Corporation was filed with the Secretary of State of the State of Delaware on April 15, 2021.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. An Amended and Restated Certificate of Incorporation was filed in the office of the Secretary of State of the State of Delaware on December 29, 2021 (the "**<u>Amended and Restated Certificate of Incorporation</u>**"), which was duly adopted by the Board of Directors of the Corporation and the stockholders of the Corporation in accordance with Section 242 of the General Corporation Law of the State of Delaware.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. A first amendment to the Amended and Restated Certificate of Incorporation was filed in the office of the Secretary of State of the State of Delaware on March 23, 2023 in connection with the Corporation's shareholder approval in connection with the shareholder meeting of the same date to amend and restate the text of Section 9.1(b) of Article IX to extend the date that the Corporation can complete its initial Business Combination (the "**<u>First Amendment to the Amended and Restated Certificate of Incorporation</u>**").

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. A second amendment to the Amended and Restated Certificate of Incorporation was filed in the office of the Secretary of State of the State of Delaware on March 28, 2024 in connection with the Corporation's shareholder approval in connection with the shareholder meeting of the same date to amend and restate the text of Section 9.1(b) of Article IX to extend the date that the Corporation can complete its initial Business Combination and make certain other amendments (the "**<u>Second Amendment to the Amended and Restated Certificate of Incorporation</u>**").

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. This Third Amendment to the Amended and Restated Certificate of Incorporation (the "**<u>Amendment</u>**") hereby:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Amends and restates <u>Section 9.1(b)</u> in its entirety and replaced, as follows:

"(b) Immediately after the Offering, a certain amount of the net offering proceeds received by the Corporation in the Offering (including the proceeds of any exercise of the underwriters' over-allotment option, if any) and certain other amounts specified in the Corporation's registration statement on Form S-1, as initially filed with the U.S. Securities and Exchange Commission (the "**<u>SEC</u>**") on July 21, 2021, as amended (the "**<u>Registration Statement</u>**"), shall be deposited in a trust account (the "**<u>Trust Account</u>**"), established for the benefit of the Public Stockholders (as defined below) pursuant to a trust agreement described in the Registration Statement (the "**<u>Trust Agreement</u>**"). Except for the withdrawal of interest to pay taxes including federal and state income taxes, and franchise taxes, and less up to $100,000 interest to pay dissolution expenses), none of the funds held in the Trust Account (including the interest earned on the funds held in the Trust Account) will be released from the Trust Account until the earliest to occur of (i) the completion of the initial Business Combination, (ii) the redemption of 100% of the Offering Shares (as defined below) if the Corporation is unable to complete its initial Business Combination by the date that is fifty-one (51) months from the effectiveness date of the Company's Form S-1 by the SEC, which was December 29, 2021, by depositing into the Trust Account $10,000 (the "<u>Extension Payment</u>"), beginning on June 29, 2025, for each one-month Extension by its due date or such earlier date as is determined by our board of directors (the "<u>board</u>"), in its sole discretion, which payment is in the Corporation's sole discretion whether to exercise one or more extensions (the "**<u>Deadline Date</u>**"), and (iii) the redemption of shares in connection with a stockholder vote to amend any provisions of this Amended and Restated Certificate (a) to modify the substance or timing of the Corporation's obligation to provide for the redemption of the Offering Shares in connection with an initial Business Combination or to redeem 100% of such shares if the Corporation has not consummated an initial Business Combination by the Deadline Date or (b) with respect to any other provision relating to stockholders' rights or pre-initial Business Combination activity (as described in Section 9.7). Holders of shares of Common Stock included as part of the units sold in the Offering (the "**<u>Offering Shares</u>**") (whether such Offering Shares were purchased in the Offering or in the secondary market following the Offering and whether or not such holders are the Sponsor or officers or directors of the Corporation, or affiliates of any of the foregoing) are referred to herein as "**Public Stockholders**."

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. This Amendment was duly adopted in accordance with the provisions of Section 242 of the DGCL by written consent of stockholders holding the requisite number of shares required by statute given in accordance with and pursuant to Section 228 of the DGCL.

[*Remainder of page intentionally left blank*]

IN WITNESS WHEREOF, Aetherium Acquisition Corp. has caused this Amended and Restated Certificate to be duly executed and acknowledged in its name and on its behalf by an authorized officer as of the date first set forth above.

---

| | |
|:---|:---|
| **AETHERIUM ACQUISITION CORP.** | **AETHERIUM ACQUISITION CORP.** |
| By: | /s/ Jonathan Chan |
| Name: | Jonathan Chan |
| Title: | Chief Executive Officer |

---

[*Signature page to Amended and Restated Certificate of Incorporation*]

## Exhibit 10.1

**Exhibit 10.1**

**AMENDMENT NO. 4**

**TO**

**INVESTMENT MANAGEMENT TRUST AGREEMENT**

THIS AMENDMENT NO. 4 TO THE INVESTMENT MANAGEMENT TRUST AGREEMENT (this"***Amendment***") is made as of July 7, 2025, by and between Aetherium Acquisition Corp., a Delaware corporation (the "***Company***"), and Continental Stock Transfer & Trust Company, a New York corporation (the "***Trustee***"). Capitalized terms contained in this Amendment, but not specifically defined in this Amendment, shall have the meanings ascribed to such terms in the Original Agreement (as defined below).

**WHEREAS**, the Company and the Trustee entered into an Investment Management Trust Agreement, dated December 29, 2021 (the "***Original Agreement***"), in connection with the its initial public offering ("***Offering***") of units of the Company (the "***Units***"), each of which is composed of one share of Class A common stock of the Company, par value $0.0001 per share (the "***Class A Common Stock***"), and of one redeemable warrant, each whole warrant entitling the holder thereof to purchase one share of Class A common stock of the Company (such initial public offering hereinafter referred to as the "***Offering***");

**WHEREAS**, $116,725,000 of the net proceeds from the Offering and the Company's private placement warrants were delivered to the Trustee to be deposited and held in the segregated Trust Account located in the United States for the benefit of the Company and the holders of Common Stock included in the Units issued in the Offering pursuant to the Original Agreement;

**WHEREAS**, the Company previously sought the approval of the holders of its Class A Common Stock and holders of its Class B common stock, par value $0.0001 per share (the "***Class B Common Stock***"), at a special meeting on March 23, 2023 to extend the date before which the Company must complete a business combination from April 3, 2023 to April 3, 2024 (or such earlier date as determined by the Company's board of directors) (the "***First Amendment***"); and

**WHEREAS**, the Company and the Trustee amended the Original Agreement on February 6, 2024, to divest the investments in United States government securities within the meaning of Section 2(a)(16) of the Investment Company Act of 1940, as amended, and instead to hold funds in an interest-bearing bank demand deposit account (the "***Second Amendment***"); and

**WHEREAS**, the Company previously sought the approval of the holders of its Class A Common Stock and holders of its Class B common stock, par value $0.0001 per share (the "***Class B Common Stock***"), at a special meeting on March 15, 2024 to extend the date before which the Company must complete a business combination from April 3, 2024 to December 29, 2024 (or such earlier date as determined by the Company's board of directors) (the "***Third Amendment***") and by depositing into the Trust Account $0.033 per non-redeeming Public Share for each extension month after April 3, 2024 till December 29, 2024; and

**WHEREAS**, the parties desire to amend the Original Agreement, as amended by the First Amendment and the Second Amendment and the Third Amendment as set forth specifically below in this Amendment.

**NOW, THEREFORE**, in consideration of the mutual agreements contained herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, and intending to be legally bound hereby, the parties hereto agree as follows:

1. <u>Amendments to Trust Agreement</u>.

(a) Section
 1(i) of the Trust Agreement is hereby amended and restated in its entirety as follows:

---

| | |
|:---|:---|
| "(i) | Commence liquidation of the Trust Account only after and promptly after (x) receipt of, and only in accordance with, the terms of a letter from the Company ("***Termination Letter***") in a form substantially similar to that attached hereto as either Exhibit A or Exhibit B, as applicable, signed on behalf of the Company by its Chief Executive Officer, Chief Financial Officer, Secretary or Chairman of the board of directors of the Company (the "***Board***") or other authorized officer of the Company, and, in the case of Exhibit A, acknowledged and agreed to by the Representative, and complete the liquidation of the Trust Account and distribute the Property in the Trust Account, including interest not previously released to the Company to pay its taxes, only as directed in the Termination Letter and the other documents referred to therein, or (y) by March 29, 2026, if a Termination Letter has not been received by the Trustee prior to such date, in which case the Trust Account shall be liquidated in accordance with the procedures set forth in the Termination Letter attached as Exhibit B and the Property in the Trust Account, including interest not previously released to the Company to pay its taxes (less up to $100,000 of interest that may be released to the Company to pay dissolution expenses) shall be distributed to the Public Stockholders of record as of such date;" |

---

(b) Section
 1 of the Trust Agreement is hereby amended by the addition of new section 1(m) as follows:

---

| | |
|:---|:---|
| "(m) | Upon receipt of an extension letter ("***Extension Letter***") substantially similar to Exhibit E hereto at least five business days prior to (A) December 29, 2024, and (B) at the Company's election, each successive monthly period ending on March 29, 2026 (each, an "***Applicable Deadline***"), signed on behalf of the Company by an executive officer, and receipt of the dollar amount specified in the Extension Letter prior to the Applicable Deadline, to follow the instructions set forth in the Extension Letter." |

---

(c) Section 1 of the Trust Agreement is hereby amended by the addition
of new section 1(n) as follows:

---

| | |
|:---|:---|
| "(n) | Beginning on December 29, 2024, until March 29, 2026 (fifty-one (51) months from the consummation of the Company's initial public offering), the Company may elect to extend the date by which the Company must consummate a business combination month-by-month each time for a total of up to fifteen (15) times by depositing $10,000 for each such one-month extension into the Company's Trust Account. If the Company fails to timely make a payment for any given month during any prior extension period or during this fifteen (15) month period, the Company elects to make an extension, the Company shall have a period of forty-five (45) days to pay any applicable past due payment (the "Cure Period"). If the Company fails to make any applicable past due payment during the Cure Period, then the Company shall immediately cease all operations, except for the purpose of winding up, liquidating and dissolving with the same effect as if the Company failed to complete a business combination within thirty-six (36) months from the consummation of the Company's initial public offering (December 29, 2024). For the avoidance of doubt, the first extension deposit will total $50,000.00 plus any unpaid deposits from Extension #2 (April 3, 2024 – December 29, 2024, pursuant to the Third Amendment), representing payment from December 29, 2024, through May 29, 2025, plus any unpaid deposits from Extension #2 (April 3, 2024 – December 29, 2024) and is due on the date that this Extension #3 pursuant to this Amendment is approved by shareholders, the shareholder meeting date. The next extension payment in the amount of $10,000.00 will be due on June 29, 2025, then monthly thereafter until February 29, 2026." |

---

2. <u>Miscellaneous Provisions</u>.

(a) <u>Entire Agreement</u>. The Original Agreement, as amended by the First, Second and Third Extension
 Amendments, and as modified by this Amendment, constitutes the entire understanding of the
 parties and supersedes all prior agreements, understandings, arrangements, promises and commitments,
 whether written or oral, express or implied, relating to the subject matter hereof, and all
 such prior agreements, understandings, arrangements, promises and commitments are hereby
 canceled and terminated.

(b) <u>Applicable Law</u>. This Amendment shall be governed by and construed and enforced in accordance with
 the laws of the State of New York.

(c) <u>Counterparts</u>.
 This Amendment may be executed in several original or facsimile counterparts, each of which
 shall constitute an original, and together shall constitute but one instrument.

**Signatures on following page.**

IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed as of the date first above written.

---

| | |
|:---|:---|
| **CONTINENTAL STOCK TRANSFER AND TRUST COMPANY**, as Trustee | **CONTINENTAL STOCK TRANSFER AND TRUST COMPANY**, as Trustee |
| By: | <br> /s/ Francis Wolf |
| Name: | Francis Wolf |
| Title: | Vice President<br>|

---

---

| | |
|:---|:---|
| **AETHERIUM ACQUISITION CORP**., as the Company | **AETHERIUM ACQUISITION CORP**., as the Company |
| By: | /s/ Jonathan Chan |
| Name: | Jonathan Chan |
| Title: | Chief Executive Officer |

---